NeoGenomics (NASDAQ:NEO) reported quarterly earnings of $0.01 per share which met the analyst consensus estimate. The company reported quarterly sales of $186.672 million which beat the analyst consensus estimate of $184.509 million by 1.17 percent. This is a 11.09 percent increase over sales of $168.035 million the same period last year.